News About: Pharm. Industry
EDI reported Plavix as the top prescription drug in 2006.
Plavix, a foreign brand prescription drug of Sanofi-Aventis, showed the top on the EDI bill changes last year while Amodipine of Hanmi kept the top among the local brands according to the 2006 EDI bill report.
...
Concerns are rising over less benefits in minor disease
The government's plan to lower health insurance benefits for treatment of minor diseases, such as common cold, from August has sparked a concern that the plan will significantly reduce the number of prescriptions, des...
Lilly to launch anti-osteoporosis drug, Fosteo.
Lilly Korea announced to launch Fosteo (teriparatide), a unique anti-osteoporosisdrug, for the promotion of bone formation.
Fosteo is a parathyroidal hormone to promote a bone formation instead of blocking an excre...
Use of RFID tags to be mandatory in drugs
The government plans to employ the radio frequency identification (RFID) or smart sensor technologies in drugs and foods, starting to replace the current barcodes as early as next year.
The RFID tag is a small inte...
Foreign-invested pharmaceutical firms increase market share
With foreign drug makers taking a bigger share of the domestic prescription market and mid-tier companies facing restructuring, Korea's pharmaceutical industry is expecting major changes.
According to Mirae Asset ...
Once-a-month drug for osteoporosis soon to launch.
A tensional atmosphere seems to surface to the 130 billion won worth of anti-osteoporosis drug markets by upcoming market launch of a new once-a-month administering drug, perhaps within this week at the earlist.
C...
Phase II study for Zydena successfully completed in U. S.
The phase II clinical study of Zydena in the United States was successfully completed and may give a good chance for its FDA approval in due course.
Dong-A PharmTec, a subsidiary of Dong-A playing a major role for ...
Hanmi wins gemicitabine patent
Hanmi Pharm announced on April it acquired a Korean patent related to a core technology of producing gemcitabine intermediate, entitled 1--halo-2,2-difluoro-2-deoxy-D-ribofuranose derivative and its manufacturing meth...
Sanofi's Actonel added indication for male osteoporosis.
Sanofi-Aventis Korea announced that the KFDA recently approved an additional indication of Actonel (risedronate sodium) for the treatment of male osteoporosis.
Actonel is a derivative of the bisphonphonates for the...
Ex-medical doctor named MSD's science ambassador
MSD Korea said on April 17 that the U.S.-based Merck Institute named Kim Kyu-chan, former Ex-medical doctor of Eulgi Hospital as a science of ambassador in Asia-Pacific region.
Kim, 57, will play a vital role in sc...
